Status:

COMPLETED

Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool

Lead Sponsor:

Ottawa Hospital Research Institute

Conditions:

Airway Extubation

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Expeditious, safe extubation is vitally important in the care of Intensive Care Unit (ICU) patients, as prolonged mechanical ventilation harms patients and failed extubation (i.e. re-intubation within...

Eligibility Criteria

Inclusion

  • In the Intensive Care Unit (ICU)
  • Able to provide informed consent (through a surrogate)
  • Invasive mechanical ventilation for \> 48 hours
  • Ready for spontaneous breathing test (SBT) for assessment for extubation
  • At least partial reversal of the condition precipitating mechanical ventilation
  • Stabilization of other organ systems
  • Toleration of pressure support ventilation less than or equal to 14 cm H2O, (oxygen saturation (SpO2) greater than or equal to 90% with fraction of inspired oxygen (FiO2) less than or equal to 40% and positive end-expiry pressure (PEEP) less than or equal to 10cm H2O)
  • Hemodynamic stability (low - phenylephrine less than 50 ug/min; norepinephrine less than 5 ug/min; dobutamine less than 5 ug/kg/min; milrinone less than 0.4 ug/kg/min - or no vasopressors)
  • Stable neurological status (no deterioration in Glasgow coma score during prior 24 hours and, if measured, intracranial pressure (ICP) less than 20 mmHg)
  • Intact airway reflexes (adequate cough with suctioning and a gag reflex)
  • Normal sinus rhythm at the time of the SBT (no pacemaker)

Exclusion

  • Order not to re-intubate should the patient fail extubation
  • Anticipated withdrawal of life support
  • Known or suspected severe weakness (myopathy, neuropathy, or quadriplegia)
  • Tracheostomy
  • Prior extubation during current ICU stay

Key Trial Info

Start Date :

October 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 13 2023

Estimated Enrollment :

31 Patients enrolled

Trial Details

Trial ID

NCT04708509

Start Date

October 4 2021

End Date

January 13 2023

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Ottawa Hospital, General Campus

Ottawa, Ontario, Canada, K1H 8L6